Pharmaceutical active Ingredient manufacturing company looking to exit

Posted On: 05 / Oct / 2023
0 233

Deal Details

Annual

Deal Type

Sell (Strategic Investors)
Maximum Loan

Industry

Pharmaceuticals
Charge

Deal Status

Active

Deal Description

  1. The company is a pharmaceutical active ingredient manufacturing company (APIs) that manufactures the raw materials for several verticals of the pharma industry. The company supplies products to all the leading pharmaceutical companies who formulate to make medicines such as Pfizer, Abbott, Cipla, Glenmark, Macleods, Aristo, etc.
  2. Turnover- 205cr.
  3. EBIDTA- 25cr.
  4. Ask- 335cr.

Reference: Shruti Bangera

No Files Attached

Deal Value
335 Crore
Targeted Region
Asia Pacific

Revenue

2019-20
Undisclosed
2020-21
Undisclosed
2021-22
205 Crore